Saturday 17 October 2026 Export TXMD’s income statement to Excel — free account

TherapeuticsMD, Inc.

TXMD Healthcare Drug Manufacturers Specialty & Generic

TherapeuticsMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 million, up 71.6% from fiscal 2024. In the quarter to June 2026, revenue fell 8.72%, EPS fell 80.0% and free cash flow grew 104.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.90 0.03 −1.55%

Follow TXMD

Alert me

Market cap: $22.3M
P/E: 0.0×
Fwd P/E: 18.9×
Dividend yield: —
F-score: 6/9
Altman Z: −34.36
Beneish M: −2.54
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	121.69	0.00	49.32	+8 more quarters Free account
P/S ratio Full definition →	7.82	6.97	6.24	4.47
P/FCF ratio Full definition →	9.40	10.06	9.07	7.27
P/Operating CF Full definition →	32.84	24.77	50.29	12.51
P/B ratio Full definition →	0.94	0.87	0.70	0.46
Price to Tangible BV Full definition →	1.09	1.00	0.82	0.53
EV/Sales Full definition →	86.16	83.60	91.57	96.83
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	90.97	103.85	112.76	129.16
EV/FCF Full definition →	103.54	120.66	133.16	157.40
Quick Ratio Full definition →	2.52	2.37	2.30	2.18
Current Ratio Full definition →	3.22	3.11	3.02	2.93
Net Debt/EBITDA Full definition →	9.65	21.15	11.58	9.29
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.09	0.09	0.08	0.07
Operating CF/Net income Full definition →	5.03	9.94	(0.61)	6.57
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Interest Coverage Full definition →	—	—	—	(287.33)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	181.47%	186.88%	256.66%	193.62%
Intangible Assets out of Total Assets Full definition →	0.09	0.10	0.10	0.10
Share Based Compensation of Revenue Full definition →	0.46%	0.28%	5.71%	0.00%
Graham Net Nets Full definition →	0.22	0.20	0.19	0.26
Graham Number Full definition →	0.00	0.93	0.00	1.08
Earnings Yield Full definition →	(1.06%)	0.82%	(3.28%)	2.03%
Free Cash Flow Yield Full definition →	10.64%	9.94%	11.02%	13.76%
Revenue per Share Full definition →	0.08	0.06	0.08	0.07
Operating CF per Share Full definition →	0.07	0.08	0.03	0.09
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.07	0.08	0.03	0.09
Cash per Share Full definition →	0.79	0.73	0.65	0.61
Shareholders Equity per Share Full definition →	2.34	2.33	2.32	2.37
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.34	2.33	2.32	2.37
Free Cash Flow Full definition →	0.78	0.94	0.38	1.00
Working Capital Full definition →	11.12	10.35	9.66	9.56
Net Current Asset Value Full definition →	5.72	4.66	3.67	3.28
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	3.57	3.10	3.54	3.49
Average Payables Full definition →	0.41	0.10	0.32	0.25
Average Assets Full definition →	38.02	37.91	38.24	39.11
Average Common Equity Full definition →	27.21	26.86	27.12	27.27

Show all line items

Columns are period end dates

Stockrow Weekly